Acute Lymphoblastic Leukemia, Pediatric Completed Phase 2 Trials for Curcumin (DB11672)

Also known as: Pediatric Acute Lymphoblastic Leukemia / Acute Lymphoblastic Leukemia in Pediatric / Pediatric Patients With Acute Lymphoblastic Leukemia / Leukemia, Lymphoblastic, Acute, Pediatric

IndicationStatusPhase
DBCOND0081765 (Acute Lymphoblastic Leukemia, Pediatric)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05045443Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic LeukemiaSupportive Care